Since the introduction of metabolic models and flux balance analysis (FBA) in systems biology, several attempts have been made to supplement these formulations with expression information to form metabolic and expression models (ME-models).
Introduction

1
Metabolic modeling, which helps understand the metabolic mechanisms occurring in a 2 biological network, is an important tool for engineering biocatalysts, with applications 3 in biofuels, drug design, and personalized medicine, among others. The accuracy of the 4 models is instrumental to the success of these applications through an efficient 5 engineering of the host organisms. However, incorporating expression information into 6 metabolic networks poses a significant challenge, and most current models do not even 7 attempt it-effectively excluding an important network in biological systems that can 8 drastically affect results. In metabolic engineering, strains are modified and controlled 9 at the genome level through the transcriptome, and the effects are observed at the 10 fluxome level, which accounts for the range of metabolic reactions in an organism. In 11 between these two levels is the proteome that actually performs the biochemical 12 transformations according to the genetic template, though it is this middle step in the 13 process that cannot yet be robustly and efficiently incorporated into models of 14 metabolic systems. Because of the complex interplay between these different layers of 15 control, understanding expression and incorporating this into future models is key for 16 improving metabolic engineering. 17 Classically, model-based strain design has relied on a tool that uses the DNA 18 sequence of an organism to detail the network of metabolic reactions that happen inside 19 a cell of that organism, which is called a genome-scale model (GEM). GEMs are 20 particularly amenable to flux balance analysis (FBA), which models metabolism at the 21 fluxome level using linear optimization techniques. However, plain FBA has been known 22 to predict biochemically unrealistic solutions like free high-flux cycles or 23 thermodynamically infeasible pathways. It also scales growth linearly with carbon 24 uptake, which is not observed at high-uptake fluxes. FBA also fails to capture 25 growth-dependent and protein-level effects, such as enzyme saturation or 26 proteome-related limitations. Hence, several efforts have been made to supplement FBA 27 with additional constraints to improve its predictive power. For example, 28 thermodynamics-based flux analysis (TFA) [1, 2] aims to add thermodynamic 29 constraints to enforce thermodynamically consistent reaction directionalities and to 30 allow the integration of metabolomics. Resource balance models add a total proteome 31 capacity constraint, as formulated in Beg et al. [3] . This allows the proteome-related 32 limitations of the cell to be modeled, as enzymes have to compete for the constrained 33 total amount of protein in the cell. Frameworks like GECKO [4] further build on this 34 resource balance idea and include flux constraints based on proteomics, using 35 constraints such as v ≤ V max = k cat [E] as well as a constraint on the total proteome 36 mass. Finally, ME-models [5] were the first to integrate the entirety of the expression 37 mechanisms of the cell from the bottom-up, including mRNA and protein synthesis. 38 However, accounting for all of these constraints at the same time is challenging 39 because of the formulation of each method, as TFA models involve integer variables that 40 yield a mixed-integer linear program (MILP), whereas ME-models involve bilinear more complex, non-linear models. Meanwhile, although resource balance models such as 48 GECKO could theoretically be integrated into TFA or ME-models in the current 49 formulations, to the best of our knowledge, no link with TFA or ME-models has been 50 proposed. Therefore, the metabolic engineering community needs a common 51 formulation for these methodologies to build the most accurate models.
52
We investigated the development of such a framework and propose herein a unified 53 formulation for Expression and Thermodynamics-enabled FLux models (ETFL) that 54 can account for the above integration issues. In ETFL, we address the compatibility of 55 the formulations by expressing the growth rate variable in bilinear products as a parameters. In this model, metabolite, enzyme, and mRNA concentration levels are 61 explicitly defined to enable fast and easy omics integration. Finally, we show an 62 application of this framework to a well characterized E. coli model, iJO1366 [10] . To be able to transparently account for expression mechanisms and increase the 66 predictive power of our models, we needed to derive the equations that could bridge the 67 biochemistry with the optimization problem that is ETFL. Here we present a summary 68 of these equations, and detail their derivation in the section Materials and Methods. We 69 derived these equations using assumptions similar to those used in the formulation of 70 the GECKO [4] and ME-model [5, 6] .
71
This formulation relies on derivations rooted in the biological mechanism of 72 expression and depends on a number of biochemical parameters related to the cell. In We can write the quasi-steady state mass balance for macromolecules as follows: 
102
Biomass reaction inclusiveness depends on the modeling assumptions made during the 103 model curation process and can vary significantly among models of the same species.
104
The consumed amount of each metabolite is usually estimated experimentally by 105 measuring the the amounts of these metabolites in dried cell mass. Because the 106 stoichiometric ratios of metabolites in the biomass reaction are fixed, the abundance of 107 metabolites is the same for all growth rates. This simplifying assumption, necessary in 108 FBA, goes against experimental evidence. Neidhardt and Curtis [9] report for instance 109 that mRNA and protein mass ratios in the cell change with growth rate.
110
Because ETFL has explicit expression requirements through transcription,
111
translation, and tRNA-charging reactions, it is possible to account for varying ratios of 112 NTPs and amino acids as the growth rate changes, an effect that is captured in 113 experiments [9] . In this context, the approximation made in FBA can be written using 114 ETFL terms:
where v biomass represents the biomass equation, and η 
Summary
121
Here we show the formulation of the constraints of ETFL. For clarity, we use different 122 indexing sets, each referring to a specific object in the model, detailed in Table 1 . The 123 variables are detailed in Table 2 , and the parameters are in Catalytic constraints
Metabolite mass balance
Expression mass balance
Degradation fluxes The main issue with the EP formulation presented above lies in the continuous bilinear 127 terms that describe the dilution of the macromolecules,
128
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. We use as a placeholder for the indexing of 129 G. Using previous notations for the synthesis, degradation, and growth rate:
In this state, the dilution term is bilinear, and the formulation requires a bilinear 131 solver or potentially a mixed-integer bilinear solver if thermodynamics are to be added. 132 The original ME-model formulation has similar terms as we are presenting here [5] . As 133 such, its recent adaptation in Lloyd et al. [6] uses the two-level algorithm SolveME [7] 134 that requires a dedicated non-linear solver. We present instead a MILP approximation 135 of the problem that makes it compatible and solvable with mainstream MILP solvers.
136
We achieve this through the discretization and linearization of the bilinear products. al. [13, 14] .
147
Let µ be an upper bound to µ, (p, N ) ∈N 2 , p ≤ N . We can approximate µ with the 148 following 0 th order approximation:
.
150
With this notation, µ N is, in fact, the resolution of the approximation. We can then 151 perform the binary expansion of p:
where log 2 N denotes the smallest majoring integer to log 2 N , and δ s ∈ {0, 1} is 153 r th digits from the right of the binary notation of p.
154
As an example, let us consider modeling an organism whose growth rate does not growth rate µ = 1.4 will be approximated by:
This example is illustrated in Fig. 1 
Linearizing the bilinearity
168
In the previous derivation, we replaced the growth rate variable by a discrete number of 169 acceptable values. We can approximate the continuous product µ * G , which represents 170 the dilution, as follows:
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The product δ l * G is then still bilinear, but one of its variables is binary. Assuming a 173 constant M > G , We can use Petersen's linearization theorem [11, 12] mRNA and enzyme content Since growth has been discretized, it is now possible 183 to also directly discretize other growth-dependent parameters of the problem, regardless 184 of whether they are in a linear or non-linear relationship with growth. This is a direct 185 consequence of the formulation of ETFL, which allows some flexibility in the modeling 186 assumptions of the user. As an example, we described the relationship between growth 187 and protein and mRNA mass ratios, P m and R m , in the cell as reported in Neidhardt 188 et al. [9] by interpolating and discretizing the protein ratio and mRNA ratio as 189 functions of the growth rate. We used type 1 special ordered set constraints (SOS1) to 190 model these variables with a first-order (piecewise linear) approximation: 
197
Additionally, it is necessary to have the integer index of λ u equal to the index of the 198 growth rate. This is obtained through the constraint:
The first term represents the growth integer index, and the second represents its growth-dependent functions given in Pramanik et al. [15] .
206
The simultaneous use of catalytic constraints on metabolic reactions (Eq. FC j , BC j ) 207 and maximal enzyme load (Eq. IC3) effectively implements allocation constraints like in 208 GECKO [4] , although in ETFL, the enzyme concentrations are also directly linked to 209 the metabolism. In GECKO, the metabolic cost of building the enzymes is not taken 210 into account. protein mass ratio in E. coli according to Neidhardt et al. [9] . The reported values (red 213 circles) are interpolated using a piecewise linear function (dashed line), which is then 214 discretized (full line). Using the integer constraints described above, the model can be 215 forced to display a protein content that corresponds to its growth. We apply the same 216 techniques to mRNA and DNA content.
217
DNA content To further increase the scope of macromolecules covered by the model, 218 it is also possible to add growth-dependent DNA content. DNA mass ratios at specific 219 growth rates are reported in Neidhardt et al. [9] . We model the DNA reaction synthesis 220 as follows:
221
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where γ is the GC content of the cell, and L bp DN A is the total length in base pairs of the 222 DNA. As with mRN A l and Enz j , DN A has a mass-balance equation of the following 223 shape:
We consider that the DNA does not degrade, meaning the only source of DNA 225 consumption is dilution caused by the growth of the cell and k
We then define 226 the molar weight of DNA M W DN A and enforce the DNA mass ratio Dm as we did 227 with both proteins and mRNA: 
In this scheme, σ X is an upper bound to X. In particular, if we consider σ X to be 
where MW(X) denotes the molecular weight of the macromolecule in SI units
250
( kg.mol −1 ≡ g.mmol −1 ), and X represents the mass fraction of the molecule in the cell. 251 We scale the fluxes using a method derived from this, detailed in the supporting file S1 252 Nondimensionalization. It is also possible to further refine this upper bound by 253 performing a variation analysis on X and re-generating a model using the newly 254 estimated upper bound.
255
For the sake of clarity, all problem formulations will be kept in their dimensionalized 256 form in the subsequent equations although the implementation is actually 257 nondimensionalized. The nondimensionalized problem is described further in S1
258
Nondimensionalization. In the ETFL formulation, enzyme synthesis is driven by the coupling between FBA and 261 EP through the catalytic constraints. To carry flux, the cell needs to produce enzymes 262 whose production will also use the metabolic resources of the cell. If allocation 263 constraints are enforced, the amount of protein and mRNA synthesized must meet 264 predefined mass ratios for the problem to be feasible. Hence, the metabolic requirement 265 terms for the expression machinery (amino acids and NTP) have been removed from the 266 biomass reaction and are accounted for in the tRNA charging and transcription 267 reactions. Thus, the FBA solutions can be recovered from the ETFL formulation by the 268 following routine:
If applicable, relaxing the allocation constraints,
273
If applicable, relaxing the thermodynamic coupling constraints. iJO366 [10] is a well-curated and well-studied GEM of E. coli that is closely related to 276 the GEM used in developing both ME-models iOL1650-ME [5] and iJL1678b-ME [6] .
277
Additionally, this model has been extensively applied in the literature and is aligned 278 with a variety of datasets that can be used for data integration. We wanted to subject 279 the model to classical studies that would highlight the power of ETFL, particularly as 280 pertains to proteome-limited growth, macromolecule concentration variability analysis, 281 and gene knock-out studies. We also wanted to assess the sensitivity of the model with 282 respect to the presence of thermodynamic constraints as well as growth-dependent 283 parameters.
284
Thus, we first experimented with four different models using ETFL with or without 285 thermodynamic constraints and growth-dependent protein/RNA/DNA allocation following Table 2 as reported by Neidhardt et al. [9] . The following Table 4 details the 287 nomenclature used to refer to these different models. The features of the most 288 constrained model containing both thermodynamic and growth-dependent parameters, 289 vETFL, are detailed in Table 5 . These four models were optimized for maximal growth 290 at increasing glucose uptake rates to assess their behavior with respect to excess 291 substrate, which will show the non-linearity of the relationship between growth and 292 glucose uptake at high uptake rates. A plateau in the growth rate was expected, which 293 indicates a proteome-limited phenotype that cannot be observed with FBA. We also 294 subsequently subject vETFL to a variability analysis and gene essentiality analysis, 295 which will respectively show us the flexibility of the model and its accuracy in 296 predicting gene knock-out behavior. To study the behavior of the model at different carbon uptake rates, we simulated 299 growth on a minimal medium with only glucose as a carbon source, unlimited oxygen, 300 and some essential inorganic compounds. This would allow us to show that at a higher 301 carbon uptake, the model would predict a limited growth -unlike FBA that would 302 predict an unlimited linear increase. Table 4 with respect to the glucose uptake of the cell. As expected and in 305 contrast to current FBA models, all four models plateau after a certain uptake rate,
306
which indicates a proteome-limited phenotype due to the limited capacity of the cells to 307 make more enzymes to metabolize the glucose. As discussed for the ME-models [5] values. We observe that this value matches the median value of the catalytic rate 341 constants in the 562 vETFL enzymes. For clarity, we will refer to these models as (i) the 342 estimated mean enzymes model; (ii) the full median model; and (iii) the partial median 343 model. The ribosome, RNA polymerase, and ATP synthase were not modified, as their 344 catalytic rates directly and strongly affect the growth of the organism. Any drastic 345 change in these would make changes related to other enzymes negligible in comparison. 346 Figure 3b shows costly and the overall uptake is limited. Finally, we observe that the differences between 365 these four models only appear at glucose uptake rates higher than 366 ≈ 6 mmol glc .DW −1 .h −1 , when the problem switches from being stoichiometry-limited to 367 proteome-limited. Thus, this experiment also illustrates the importance of well curated 368 catalytic rate constants for modeling organisms grown in proteome-limited regimens.
369
These results demonstrate the capability of ETFL to predict different phenotypes 370 depending on growth rate. ETFL is also amenable to hypothesis testing, as evidenced 371 using the models that estimate the missing enzymes. In particular, we showed with 372 ETFL that an uptake increase does not yield a proportional growth rate increase as 373 with FBA and that ETFL provides a maximal uptake rate that is unmodeled in FBA, 374 thus more effectively modeling growth-dependent biomass yield in E. coli . This allows 375 for more realistic predictions for phenotypes that are limited by the expression 376 capabilities of the cell as well as captures the variability of the biomass composition in 377 different growth regimens. 
Variability analysis
379
It is also possible to subject the model to a range of variability analyses. These are Concentration variability of peptide species, sorted by average peptide concentration (darker disc). Lower bounds that were 0 were set to the accuracy of the solver, 10 −9 . The horizontal line on the left side of the figure represents ribosomal peptides, which is narrow due to their instrumental role in making the tightly constrained amount of protein in the cell at a given growth rate. The vertical line in the middle represents the dummy peptide, which accounts for unmodeled peptides (non-metabolic proteins and enzymes with missing information) and therefore is used by the solver as a slack. are always present at this uptake rate and are hence necessary for the cell to grow at an 391 optimum growth rate. The same study can be performed for enzyme concentrations or 392 even metabolite log-concentrations for models with thermodynamics. This type of study 393 is useful for comparing how the model performs in relation to actual proteomics, 394 transcriptomics, or metabolomics data. The method for running these other types of 395 variability analyses is exactly the same -only the variables subject to the variability 396 analysis are changed.
397
A specific usage of a variability analysis is the study of the allowed proteome (resp. 398 transcriptome) that is done by performing a variability analysis on the enzyme (mRNA) 399 concentration variables. This type of study can, for instance, be compared with space, it is a solution to the problem. This observation is then plotted on a finite area, 405 which can be done using the online software Proteomaps [17, 18] . This method and (sub)group of mRNAs.
417
We used the mean of the variability analysis as the observation rather than a single 418 optimal solution because the optimality principle in LP only guarantees a unique global 419 optimum value and not a unique optimal solution. Moreover, solver heuristics give 17/33
Essentiality analysis
423
The ETFL framework can also analyze the essentiality of specific genes by performing 424 single gene knockouts. Boolean rules that directly set metabolic reaction rates to 0 if the knocked-out gene is 435 essential to this reaction. The difference is that in ETFL, the solver actually sees the 436 knock-out as a part of the model, while FBA changes the model to accommodate the 437 knock-out. This feature can be used in strain design strategies to optimize directly for 438 knock-outs. The results are presented in Table 7 and We observe that, compared to iJO1366, (i) ETFL presents more false positives
441
(experimentally essential genes predicted as non-essential); and (ii) ETFL predicts fewer 442 false negatives (experimentally non-essential genes predicted as essential). This first 443 point might indicate that ETFL is less constrained than iJO1366-the cell has more 444 genetic alternatives for growth. This is an artificial effect that likely stems from the 445 missing enzyme data, because if a reaction depends on a missing enzyme, by default 446 there will be no coupled expression and hence no impact if the related gene is knocked 447 out. As more enzyme data is added to the model, the false positive rate should decrease. 448 The second point indicates that ETFL better captures the genes that are not essential 449 for growth than iJO1366. This is an expected effect of explicit expression coupling, from 450 transcription to enzyme concentration, as opposed to Boolean gene reaction rules.
451
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Performance
466
ETFL relies on solver-specific MILP algorithms and heuristics, which also means that 467 great variability in performances can be observed depending on the solver parameters. 468 We provide tuned presets for different tasks (gene knock-out, variability analysis,
469
growth maximization) with the package, and recommend that users run their own solver 470 tuning if long run times are observed. We witnessed an up to 10× increase in 471 performance using such tuning. REMI [22] , iMAT [23] , GIMME [24] , or MINEA [25] , can also be adequately 489 reformulated for ETFL. Metabolomics can still be integrated using TFA [1, 2] .
490
Minimization of adjustment In the original paper, the hypothesis behind the
491
Minimization of Metabolic Adjustment (MOMA) method is that the metabolic fluxes of 492 an organism subject to a gene knock out show a minimal change compared to the 493 metabolic fluxes of the wild-type organism [26] . The underlying hypothesis is that the 494 enzyme distribution and assignments remain the same except for the knocked-out gene. 
where · p is either the Manhattan norm (p = 1, 1 -norm) or the Euclidean norm (p = 2, 2 -norm), which will require a MIQP solver. In the same fashion, it is also possible to formulate a (weighted) Minimization of mRNA Adjustment (MORA) or even a Minimization of eXpression Adjustment (MOXA) using the following formulations:
Parsimonious analysis Parsimonious FBA (pFBA) [20] Several parameter values were taken from the BioNumbers database [28] , and when 542 used, their identification number as well as the original source from which the value was 543 reported are specified. 
Preliminaries, Conventions, and Notations
545
We will write the mass balances for the macromolecules with included concentration 546 variables. Because we assume the cell is growing at a growth rate µ, we must assume 547 that the volume in which the mass balance is calculated varies.
548
The time derivative of the concentration of a macromolecule G of concentration C G 549 in the volume V , for a total mass m G in the cell, produced at a rate v syn G and degraded 550 at a rate v deg G , will be written:
We can combine equations 14 and 15 and divide by V (necessarily non-zero) to write 552 the time derivative of the concentration C G :
By definition, 1 V dV dt = µ is the growth rate of the cell, and we call the term µ · C G 554 the dilution term, or v dil G , as per Fredrickson's work on formulating growth models [29] . 555 It is a common assumption that the concentrations inside the cell remain time invariant 556 (quasi-steady state assumption), effectively yielding the constraint:
It is also understood from the formulation of the FBA that adding a new reaction to 558 the system, such as:
results in adding terms to the mass balances of A and B :
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The further extension of this to reactions of n reactants to m products is trivial.
562
Several parameter values are taken from the BioNumbers database [28] . When used, 563 we specify their identification number as well as the original source from which the 564 value was reported. Finally, we will represent products between a parameter value and a 565 variable by the symbol " · " and products between two variables by the symbol " * ".
566
Hereafter, we propose a detailed top-down approach to formulate the constraints 567 being built for ETFL, starting from the metabolite network and moving down to RNA 568 synthesis. 
Metabolic reactions
570
From FBA, the mass-balance relationship for metabolites can be written as:
For the rest of the formulation, it is necessary to split the net flux v from each 572 reaction into its forward net component and backward net component:
Biochemical reactions are catalyzed by enzymes. Each enzyme (Enz j ) of concentration 574 E j can catalyze a flux v j subject to the enzyme capacity constraint, which is a function 575 of its forward and backward catalytic rate constants k j,+ cat and k j,− cat :
The distinction between the bounds of the forward and backward net fluxes is 577 important, as some enzymes have different catalytic activities depending on the 578 direction of the flux. 
Enzyme assembly
580
Each enzyme Enz j in concentration E j is subject to mass balance, which can be 581 written:
which reads under quasi-steady state assumption (QSSA):
where v asm j is the formation rate of the enzyme by the assembly of its constituent 584 peptides, v deg j is the degradation rate, v dil j is the dilution rate, and µ is the growth rate 585 of the cell. The formation rate of the enzyme describes the assembly of free peptides, so 586 it is necessary to add the peptide assembly reaction to the stoichiometric matrix: 
where η j l is the stoichiometric coefficient of peptide P ep l for the formation of the 588 complex of enzyme Enz j . The synthesis of peptides consumes charged tRNAs, which are subsequently uncharged 591 during the current peptide synthesis by a ribosome. The process consumes 2 GTP and 592 releases 2 GDP and 2 Pi per amino acid:
where aa i denotes the i th amino acid, η In particular, the peptide concentrations obey the mass-balance equation:
We assume in the current model that the assembly rates are much faster than 602 dilution and degradation, and thus simplify this mass balance to:
which, under QSSA, can be written:
In this context, the peptides are treated just like regular metabolites in the system.
605
This assumption in PB l can be relaxed without a loss of generality by introducing a 606 dilution and a degradation term, thus introducing a bilinearity.
607
Finally, we must take into account the actual degradation reactions. We add the 608 ideal degradation reaction to the system:
For this, the degradation rate is known: The peptides are the product of a translation reaction that is catalyzed by a ribosome. [30] ), L aa l is the amino acid length of the peptide l, 617 and R l is the quantity of ribosomes assigned to the translation of this peptide. This 618 way, the ratio R l /P ep l is effectively the average polysome size translating the peptide l. 619 Like any other enzyme, ribosomes verify the mass balance: E rib denotes the total quantity of ribosomes in a cell. It accounts for R l , the 621 ribosomes assigned to the translation of P ep l , as well as the free ribosomes in the cell, 622 R F . We can then write the total ribosome capacity constraint:
If we know the ratio ρ of free versus occupied ribosomes, we can enforce it:
Finally, the ribosome differs from other enzymes in that it takes ribosomal peptides 625 rPep l as well as ribosomal RNA rRNA l for its assembly. Hence, its assembly reaction is: 626 
As explained earlier, the stoichiometric coefficients η rib will appear in the mass 627 balances of each of the compounds of the reaction. 
635
RNAP is an enzyme, and hence it also satisfies mass balance: where E RN AP is the total amount of RNAP, which also accounts for free RNAP P F , 637 and follows: As we did with the ribosomes, if we know the ratio of occupied RNAP, π, we can is its transcription (synthesis) rate. F l is to mRN A l what E j 645 is to Enz j -the concentration variable that represents the macromolecule in the EP.
646
The transcription reaction is modeled as follows: Again, the stoichiometric coefficients will appear in the mass balances of each of the 648 metabolites and macromolecules involved.
649
We must also take into account the relationship between ribosome assignment and 650 mRNA concentration. On each strand of mRN A l , there can be only a finite number ρ l 651 of ribosomes translating at the same time. This number is given by the ratio of the amounts to approximately 60 base pairs (the length of a nucleotide is approximately 0.3 657 nm; BNID 103777 [33] ). From there we can get the additional constraint:
Finally, we must take into account the actual degradation reactions. We consider 660 perfect degradation for mRNAs:
